Compounds > clarithromycin
Page last updated: 2024-08-25

clarithromycin and Carcinoma, Non-Small Cell Lung

clarithromycin has been researched along with Carcinoma, Non-Small Cell Lung in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (50.00)18.2507
2000's4 (28.57)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daimon, T; Eto, T; Hatori, M; Hayashi, H; Ikeda, M; Inoue, K; Itoh, K; Kamezato, M; Taku, K; Tsuji, D1
Che, XF; Hiramoto, M; Ito, K; Miyazawa, K; Moriya, S; Sugita, S; Yamashiro, Y; Yokoyama, T1
Awan, S; Baldwin, D; Crosby, V; Hennig, I; Ndlovu, M; Paradine, S; Potter, V; Wilcock, A1
Igarashi, T; Masada, M; Nakamura, T; Tani, D; Tsukamoto, H; Watanabe, K; Yano, R1
Hamada, K; Kita, E; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S1
Hamada, K; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S; Tsujimoto, M3
Goto, G; Ieshiro, R; Iguchi, M; Okamura, J; Ota, T; Yuasa, K2
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Ueda, K; Yoshimoto, E1
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E1
Konishi, Y; Mikasa, K; Murakawa, Y; Murata, N; Narita, N; Sasaki, Y; Tsujiuchi, T; Tsutsumi, M1
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M1

Trials

3 trial(s) available for clarithromycin and Carcinoma, Non-Small Cell Lung

ArticleYear
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Jan-10, Volume: 86, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Middle Aged

1997
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer--the second report].
    The Japanese journal of antibiotics, 1998, Volume: 51 Suppl A

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Survival Rate

1998
Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer.
    Chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Aged; Biomarkers; Body Weight; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Combined Modality Therapy; Disease Progression; Female; Humans; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Protein Synthesis Inhibitors; Survival Analysis; Treatment Outcome; Weight Gain

2001

Other Studies

11 other study(ies) available for clarithromycin and Carcinoma, Non-Small Cell Lung

ArticleYear
Retrospective analysis of severe neutropenia in patients receiving concomitant administration of docetaxel and clarithromycin.
    Chemotherapy, 2013, Volume: 59, Issue:6

    Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Odds Ratio; Retrospective Studies; Severity of Illness Index; Sex Factors; Taxoids

2013
EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells.
    Biochemical and biophysical research communications, 2015, May-22, Volume: 461, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Clarithromycin; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Treatment Outcome

2015
Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study.
    Lung cancer (Amsterdam, Netherlands), 2017, Volume: 104

    Topics: Anti-Bacterial Agents; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Feasibility Studies; Female; Humans; Lung Neoplasms; Macrolides; Male; Medication Adherence; Neoplasm Staging; Placebos; Randomized Controlled Trials as Topic

2017
Evaluation of potential interaction between vinorelbine and clarithromycin.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Cohort Studies; Drug Interactions; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Sex Characteristics; Vinblastine; Vinorelbine

2009
[Efficacy of clarithromycin on cancer cachexia in patients with primary non-small cell lung cancer].
    The Japanese journal of antibiotics, 1997, Volume: 50 Suppl A

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-6; Lung Neoplasms; Male; Tumor Necrosis Factor-alpha

1997
[Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration].
    The Japanese journal of antibiotics, 1997, Volume: 50 Suppl A

    Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-12; Lung Neoplasms; Male; RNA, Messenger

1997
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
    The Japanese journal of antibiotics, 1997, Volume: 50 Suppl A

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Survival Rate

1997
[Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer].
    The Japanese journal of antibiotics, 1998, Volume: 51 Suppl A

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Female; Humans; Immunologic Factors; Interferon-gamma; Interleukin-12; Lung Neoplasms; Male; Middle Aged; RNA, Messenger

1998
[Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Killer Cells, Natural; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged

1998
[Administration of clarithromycin (CAM) to non-small cell lung cancer].
    The Japanese journal of antibiotics, 2000, Volume: 53 Suppl A

    Topics: Adenocarcinoma; Aged; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Disease Models, Animal; Female; Humans; Immunologic Factors; Interferon-gamma; Interleukin-10; Interleukin-12; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL

2000
[Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
    The Japanese journal of antibiotics, 2001, Volume: 54 Suppl A

    Topics: Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etodolac; Lung Neoplasms; Male; Nitrosamines; Pneumonia; Rats; Rats, Wistar

2001